In April, the American Society of Clinical Oncology (ASCO) released a policy statement recommending how to fix the 340B Drug Pricing Program.
[ Read More ]
We use cookies to ensure that we give you the best experience on our website. By continuing to browse the site, you are agreeing to this use and our Privacy Policy.